Loteprednol/tobramycin ophthalmic Interactions
There are 51 drugs known to interact with loteprednol/tobramycin ophthalmic, along with 2 disease interactions. Of the total drug interactions, 1 is major, and 50 are moderate.
- View all 51 medications that may interact with loteprednol/tobramycin ophthalmic
- View loteprednol/tobramycin ophthalmic disease interactions (2)
Most frequently checked interactions
View interaction reports for loteprednol / tobramycin ophthalmic and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Breo Ellipta (fluticasone / vilanterol)
- CellCept (mycophenolate mofetil)
- Centrum Silver Men's (multivitamin with minerals)
- Coreg (carvedilol)
- Crestor (rosuvastatin)
- Diflucan (fluconazole)
- Dupixent (dupilumab)
- Effexor XR (venlafaxine)
- Entresto (sacubitril / valsartan)
- EpiPen (epinephrine)
- Flomax (tamsulosin)
- Lokelma (sodium zirconium cyclosilicate)
- Maxitrol (dexamethasone / neomycin / polymyxin b ophthalmic)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- MS Contin (morphine)
- Narcan (naloxone)
- Neosporin Ophthalmic (gramicidin / neomycin / polymyxin b ophthalmic)
- Neosporin Ophthalmic Ointment (bacitracin / neomycin / polymyxin b ophthalmic)
- NPH Insulin (insulin isophane)
- Ozempic (semaglutide)
- ProAir HFA (albuterol)
- Protonix (pantoprazole)
- TobraDex (dexamethasone / tobramycin ophthalmic)
- Total Allergy (diphenhydramine)
- Tresiba (insulin degludec)
Loteprednol/tobramycin ophthalmic disease interactions
There are 2 disease interactions with loteprednol / tobramycin ophthalmic which include:
More about loteprednol / tobramycin ophthalmic
- loteprednol/tobramycin ophthalmic consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.